Ligand Pharmaceuticals Inc
LGND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000886163
In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; 416 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
Superinvestors holding LGND, Q2 2026
No superinvestor reported holding LGND in Q2 2026.